Recent Patents on Cardiovascular Drug Discovery

Continued as Recent Advances in Cardiovascular Drug Discovery

Personal Subscription

Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase

Volume:1   Issue: 2
Pp: 129-139
Nangaku Nangaku, Ichiro Kojima, Tetsuhiro Tanaka, Takamoto Ohse, Hideki Kato and Fujita Fujita
DOI: 10.2174/157489006777442522

Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications

Volume:1   Issue: 2
Pp: 167-175
Zia A. Khan and Subrata Chakrabarti
DOI: 10.2174/157489006777442531

Vasopressin Receptor Antagonists in Heart Failure

Volume:1   Issue: 2
Pp: 177-184
Robert E. Hobbs and W. H. Wilson Tang
DOI: 10.2174/157489006777442513

Levosimendan: A Novel Agent in Heart Failure

Volume:1   Issue: 2
Pp: 185-191
Nikolas Koumallos, Charalambos Antoniades, Dimitris Tousoulis, Cheerag Shirodaria and Christodoulos Stefanadis
DOI: 10.2174/157489006777442487

Role of PPAR in Cardiovascular Diseases

Volume:1   Issue: 2
Pp: 193-209
Saibal K. Das and Ranjan Chakrabarti
DOI: 10.2174/157489006777442441

Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs

Volume:1   Issue: 2
Pp: 211-224
Gregory J. Chen and Reza Forough
DOI: 10.2174/157489006777442478

Patent Annotations

Volume:1   Issue: 2
Pp: 225-227

DOI: 10.2174/157489006777442504

Patent Selections promotion: free to download

Volume:1   Issue: 2
Pp: 229-231

DOI: 10.2174/157489006777442469